Achievements｜Department of Virology, Institute of Tropical Medicine, Nagasaki University

Articles/Books

2022-01-07

Mya Myat Ngwe Tun, Takaya Sakura, Yasuteru Sakurai, et al.

Antiviral activity of 5-aminolevulinic acid against variants of severe acute respiratory syndrome coronavirus 2

Articles/Books

2022-01-04

Haruka Abe, Yuri Ushijima, Murasaki Amano, et al.

Unique Evolution of SARS-CoV-2 in the Second Large Cruise Ship Cluster in Japan

Articles/Books

2022-01-04

Taichirao Takemura, Co Thach Nguyen, Ha Chau Pham, et al.

The 2017 Dengue virus 1 outbreak in northern Vietnam was caused by a locally circulating virus group

Others

2022-01-01

Yuki Takamatsu

Yuki Takamatsu has been accepted for the research grant "MSD Life Science Foundation Medical Encouragement Award"　Research topic: VP30 protein phosphorylation regulating Ebola virus transcription and its application to therapeutics.

Presentations

2021-12-10

Zhan Qiu Mao

Direct real-time RT-qPCR for the detection of SARS-CoV-2 with co-circulation of DENV-2 and ZIKV in resource-limited settings.

Presentations

2021-12-10

Jean Claude Balingit

Antibody-dependent enhancement in the long-term humoral immunity against dengue virus serotype 1 infection.

Presentations

2021-12-10

Elizabeth Ajema Chebichi Luvai

Congenital Chikungunya virus infection in Vietnam, 2017-2018.

Presentations

2021-12-10

Sandra Kendra Raini

The first report of seroepidemiological evidence of ZIKV transmission in Sri Lanka.

Presentations

2021-12-10

Khine Mya Nwe

Clilnical, virological and immunological features in cosmopolitan genotype of DENV-2 infected patients during 2017 outbreak in Sri Lanka.

Presentations

2021-11-16

Jean Claude Palma Balingit

Paper

Antiviral activity of 5-aminolevulinic acid against variants of severe acute respiratory syndrome coronavirus 2

Unique Evolution of SARS-CoV-2 in the Second Large Cruise Ship Cluster in Japan

The 2017 Dengue virus 1 outbreak in northern Vietnam was caused by a locally circulating virus group

Yuki Takamatsu has been accepted for the research grant "MSD Life Science Foundation Medical Encouragement Award"　Research topic: VP30 protein phosphorylation regulating Ebola virus transcription and its application to therapeutics.

Direct real-time RT-qPCR for the detection of SARS-CoV-2 with co-circulation of DENV-2 and ZIKV in resource-limited settings.

Antibody-dependent enhancement in the long-term humoral immunity against dengue virus serotype 1 infection.

Congenital Chikungunya virus infection in Vietnam, 2017-2018.

The first report of seroepidemiological evidence of ZIKV transmission in Sri Lanka.

Clilnical, virological and immunological features in cosmopolitan genotype of DENV-2 infected patients during 2017 outbreak in Sri Lanka.

DENV-1 Genotype Variance Drives Discrepancies in Homotypic Neutralizing and Enhancing Activities of Antibodies during Natural Infections.

Paper

Antiviral activity of 5-aminolevulinic acid against variants of severe acute respiratory syndrome coronavirus 2

Unique Evolution of SARS-CoV-2 in the Second Large Cruise Ship Cluster in Japan

The 2017 Dengue virus 1 outbreak in northern Vietnam was caused by a locally circulating virus group

Yuki Takamatsu has been accepted for the research grant "MSD Life Science Foundation Medical Encouragement Award" Research topic: VP30 protein phosphorylation regulating Ebola virus transcription and its application to therapeutics.

Direct real-time RT-qPCR for the detection of SARS-CoV-2 with co-circulation of DENV-2 and ZIKV in resource-limited settings.

Antibody-dependent enhancement in the long-term humoral immunity against dengue virus serotype 1 infection.

Congenital Chikungunya virus infection in Vietnam, 2017-2018.

The first report of seroepidemiological evidence of ZIKV transmission in Sri Lanka.

Clilnical, virological and immunological features in cosmopolitan genotype of DENV-2 infected patients during 2017 outbreak in Sri Lanka.

DENV-1 Genotype Variance Drives Discrepancies in Homotypic Neutralizing and Enhancing Activities of Antibodies during Natural Infections.

Yuki Takamatsu has been accepted for the research grant "MSD Life Science Foundation Medical Encouragement Award"　Research topic: VP30 protein phosphorylation regulating Ebola virus transcription and its application to therapeutics.